ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OCR

97.90
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NYSE:OCR NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 97.90 0.00 01:00:00

OMNICARE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

21/05/2015 6:52pm

PR Newswire (US)


Omnicare (NYSE:OCR)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Omnicare Charts.

WILMINGTON, Del., May 21, 2015 /PRNewswire/ -- Rigrodsky & Long, P.A.:

  • Do you own shares of Omnicare, Inc. (NYSE: OCR)?
  • Did you purchase any of your shares prior to May 21, 2015?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Omnicare, Inc. ("Omnicare" or the "Company") (NYSE: OCR) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by CVS Health Corporation ("CVS") (NYSE: CVS), in a transaction valued at approximately $12.7 billion.

Click here to learn more: http://rigrodskylong.com/investigations/omnicare-inc-ocr.     

Under the terms of the agreement, shareholders of Omnicare will receive $98.00 in cash for each share of Omnicare they own.

The investigation concerns whether Omnicare's board of directors failed to adequately shop the Company and obtain the best possible value for Omnicare's shareholders before entering into an agreement with CVS.  According to Yahoo! Finance, at least one analyst has issued a price target for Omnicare stock at $104.00 per share.

If you own the common stock of Omnicare and purchased your shares before May 21, 2015, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at: http://rigrodskylong.com/investigations/omnicare-inc-ocr.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:                                                                                              

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com 
http://www.rigrodskylong.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/omnicare-inc-shareholder-alert-rigrodsky--long-pa-announces-investigation-of-buyout-300087461.html

SOURCE Rigrodsky & Long, P.A.

Copyright 2015 PR Newswire

1 Year Omnicare Chart

1 Year Omnicare Chart

1 Month Omnicare Chart

1 Month Omnicare Chart

Your Recent History

Delayed Upgrade Clock